390 related articles for article (PubMed ID: 37389674)
1. The Role of P53 in Myocardial Ischemia-Reperfusion Injury.
Zhu XZ; Qiu Z; Lei SQ; Leng Y; Li WY; Xia ZY
Cardiovasc Drugs Ther; 2023 Jun; ():. PubMed ID: 37389674
[TBL] [Abstract][Full Text] [Related]
2. The pathological mechanisms and potential therapeutic drugs for myocardial ischemia reperfusion injury.
Zhang S; Yan F; Luan F; Chai Y; Li N; Wang YW; Chen ZL; Xu DQ; Tang YP
Phytomedicine; 2024 Jul; 129():155649. PubMed ID: 38653154
[TBL] [Abstract][Full Text] [Related]
3. Research Progress on the Role of Pyroptosis in Myocardial Ischemia-Reperfusion Injury.
Liu Y; Zhang J; Zhang D; Yu P; Zhang J; Yu S
Cells; 2022 Oct; 11(20):. PubMed ID: 36291138
[TBL] [Abstract][Full Text] [Related]
4. The Regulatory Role of Non-coding RNA in Autophagy in Myocardial Ischemia-Reperfusion Injury.
Wang D; Niu Z; Wang X
Front Pharmacol; 2022; 13():822669. PubMed ID: 35370737
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between programmed cell death and myocardial ischemia-reperfusion injury and new perspectives of traditional Chinese medicine intervention].
Xie YZ; Ma J; Yao GZ; Zou X
Zhongguo Zhong Yao Za Zhi; 2021 Mar; 46(6):1345-1356. PubMed ID: 33787131
[TBL] [Abstract][Full Text] [Related]
6. The Function of Circular RNAs in Myocardial Ischemia-Reperfusion Injury: Underlying Mechanisms and Therapeutic Advancement.
Chen KY; Liu Z; Lu JH; Yang SY; Hu XY; Liang GY
Cardiovasc Drugs Ther; 2024 Jan; ():. PubMed ID: 38289452
[TBL] [Abstract][Full Text] [Related]
7. Acetylation, ferroptosis, and their potential relationships: Implications in myocardial ischemia-reperfusion injury.
Yang Y; Ma M; Su J; Jia L; Zhang D; Lin X
Am J Med Sci; 2023 Sep; 366(3):176-184. PubMed ID: 37290744
[TBL] [Abstract][Full Text] [Related]
8. Adenosine 2 receptor regulates autophagy and apoptosis to alleviate ischemia reperfusion injury in type 2 diabetes via IRE-1 signaling.
Yacouba Moukeila MB; Thokerunga E; He F; Bongolo CC; Xia Y; Wang F; Gado AF; Mamoudou H; Khan S; Ousseina B; Ousmane HA; Diarra D; Ke J; Zhang Z; Wang Y
BMC Cardiovasc Disord; 2023 Mar; 23(1):154. PubMed ID: 36964482
[TBL] [Abstract][Full Text] [Related]
9. Down-Regulation of miR-327 Alleviates Ischemia/Reperfusion-Induced Myocardial Damage by Targeting RP105.
Yang Y; Yang J; Liu XW; Ding JW; Li S; Guo X; Yang CJ; Fan ZX; Wang HB; Li Q; Wang HM; Yang J
Cell Physiol Biochem; 2018; 49(3):1049-1063. PubMed ID: 30196287
[TBL] [Abstract][Full Text] [Related]
10. Network Pharmacology-Based Investigation and Experimental Exploration of the Antiapoptotic Mechanism of Colchicine on Myocardial Ischemia Reperfusion Injury.
Tang Y; Shi C; Qin Y; Wang S; Pan H; Chen M; Yu X; Lou Y; Fan G
Front Pharmacol; 2021; 12():804030. PubMed ID: 34975499
[No Abstract] [Full Text] [Related]
11. [Regulation of myocardial ischemia reperfusion injury signal pathway by flavonoid monomer].
Hu YQ; Liu JH
Zhongguo Zhong Yao Za Zhi; 2023 Feb; 48(4):879-889. PubMed ID: 36872258
[TBL] [Abstract][Full Text] [Related]
12. Sp1 Targeted PARP1 Inhibition Protects Cardiomyocytes From Myocardial Ischemia-Reperfusion Injury via Downregulation of Autophagy.
Xu Y; Wang B; Liu X; Deng Y; Zhu Y; Zhu F; Liang Y; Li H
Front Cell Dev Biol; 2021; 9():621906. PubMed ID: 34124031
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Myocardial Cell Apoptosis Is Important Mechanism for Ginsenoside in the Limitation of Myocardial Ischemia/Reperfusion Injury.
Chen Z; Wu J; Li S; Liu C; Ren Y
Front Pharmacol; 2022; 13():806216. PubMed ID: 35300297
[TBL] [Abstract][Full Text] [Related]
14. Research Progress of Chinese Medicine in the Treatment of Myocardial Ischemia-Reperfusion Injury.
Dong L; Shen Z; Chi H; Wang Y; Shi Z; Fang H; Yang Y; Rong J
Am J Chin Med; 2023; 51(1):1-17. PubMed ID: 36437553
[TBL] [Abstract][Full Text] [Related]
15. Management of ROS and Regulatory Cell Death in Myocardial Ischemia-Reperfusion Injury.
Gong G; Wan W; Zhang X; Chen X; Yin J
Mol Biotechnol; 2024 Jun; ():. PubMed ID: 38852121
[TBL] [Abstract][Full Text] [Related]
16. Research on cardioprotective effect of irbesartan in rats with myocardial ischemia-reperfusion injury through MAPK-ERK signaling pathway.
Ren GD; -Y Cui Y; Li WL; Li FF; Han XY
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5487-5494. PubMed ID: 31298402
[TBL] [Abstract][Full Text] [Related]
17. Characterization of novel lncRNAs in upper thoracic spinal cords of rats with myocardial ischemia-reperfusion injuries.
Li ZX; Li YJ; Wang Q; He ZG; Feng MH; Xiang HB
Exp Ther Med; 2021 Apr; 21(4):352. PubMed ID: 33732325
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of miR-217 Protects Against Myocardial Ischemia-Reperfusion Injury Through Inactivating NF-κB and MAPK Pathways.
Li Y; Fei L; Wang J; Niu Q
Cardiovasc Eng Technol; 2020 Apr; 11(2):219-227. PubMed ID: 31916040
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of Action of Flavonoids of
Guo Y; Zhang BY; Peng YF; Chang LC; Li ZQ; Zhang XX; Zhang DJ
Molecules; 2022 Mar; 27(5):. PubMed ID: 35268807
[No Abstract] [Full Text] [Related]
20. A bibliometric study related to the treatment of myocardial ischemia-reperfusion Injury.
Feng J; Han L; Liu Y; Li K; Wu Y
J Cardiothorac Surg; 2024 Jul; 19(1):409. PubMed ID: 38951938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
